BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16337032)

  • 21. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
    Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
    J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bugs among us.
    Coffman S
    Nurs Manage; 2007 Oct; 38(10):33-40; quiz 40-1. PubMed ID: 17914302
    [No Abstract]   [Full Text] [Related]  

  • 23. Trafficking of methicillin-resistant staphylococci and co-colonization with vancomycin-resistant enterococci.
    Sharaf EJ; Senok AC; Udo EE; Botta GA
    Med Princ Pract; 2011; 20(3):253-8. PubMed ID: 21454996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A guide to TB, VRE, and MRSA.
    RN; 1998 Jul; 61(7):24DD. PubMed ID: 9687812
    [No Abstract]   [Full Text] [Related]  

  • 25. [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].
    Cantón R; Ruiz-Garbajosa P
    Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):543-51. PubMed ID: 24041416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 28. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methicillin resistant Staphylococcus aureus: where are we now?
    Allen DM
    Singapore Med J; 1991 Feb; 32(1):17-9. PubMed ID: 2017696
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the impact of a program for the control of methicillin-resistant Staphylococcus aureus].
    Fernández C; Cruzet F; Coello R
    Enferm Infecc Microbiol Clin; 1992 Nov; 10 Suppl 3():58-60. PubMed ID: 1477133
    [No Abstract]   [Full Text] [Related]  

  • 31. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of alcohol-based, waterless hand antiseptic on the incidence of infection and colonization with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Lai KK; Fontecchio S; Melvin Z; Baker SP
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1018-24. PubMed ID: 17006807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant Staphylococcus Aureus (MRSA).
    Ashwin KS; Muralidharan NP
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():166-7. PubMed ID: 25657146
    [No Abstract]   [Full Text] [Related]  

  • 34. Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999-2002.
    Burger T; Fry D; Fusco R; Luschini M; Mayo JB; Ng V; Roye-Horn K; Wagner N
    Am J Infect Control; 2006 Sep; 34(7):458-64. PubMed ID: 16945694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of steps taken for the control of a methicillin-resistant Staphylococcus aureus infection outbreak at a neonatology unit].
    Campins M; Almar J; Rodríguez V; Jasa A; Ruiz MA; Gasser I
    Enferm Infecc Microbiol Clin; 1992 Nov; 10 Suppl 3():56-8. PubMed ID: 1477132
    [No Abstract]   [Full Text] [Related]  

  • 36. A flexible approach to methicillin-resistant Staphylococcus aureus (MRSA).
    Nolan JL
    Nurs Times; 2001 Nov 15-21; 97(46):57-8. PubMed ID: 11966057
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methicillin-resistant Staphylococcus aureus and healthcare associated infection surveillance.
    Wilcox MH; Swann A
    J Hosp Infect; 2002 Jan; 50(1):80-1. PubMed ID: 11825058
    [No Abstract]   [Full Text] [Related]  

  • 39. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization.
    Furuno JP; Perencevich EN; Johnson JA; Wright MO; McGregor JC; Morris JG; Strauss SM; Roghman MC; Nemoy LL; Standiford HC; Hebden JN; Harris AD
    Emerg Infect Dis; 2005 Oct; 11(10):1539-44. PubMed ID: 16318693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin-resistant Staphylococcus aureus--New York, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(15):322-3. PubMed ID: 15103297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.